Recently, activation of TYK2 has been noted in a number of malignancies including T-cell acute lymphoblastic leukemia (T-ALL), anaplastic large cell lymphoma (ALCL) and nerve sheath tumor [3–6]. Here, TYK2 is linked to anaplastic large cell lymphoma.